Bavarian Nordic CEO Hopes Chordoma Vaccine Can Be Launched By Mid-2020
Danish vaccine specialist's BN-Brachyury has been granted orphan drug designation by the FDA for treating chordoma.

Danish vaccine specialist's BN-Brachyury has been granted orphan drug designation by the FDA for treating chordoma.